Takeda has a licensing and collaboration agreement to commercialize our pharmaceutical product AMITIZA® in the United States and Canada.
Takeda has a license, development, commercial and supply agreement for our pharmaceutical product AMITIZA to further develop and commercialize AMITIZA in all global markets except Japan and China.
Par® has a settlement and license agreement related to AMITIZA 8 mcg and 24 mcg soft gelatin capsules for CIC and IBS-C.
The Par Pharmaceutical logo, “Par Pharmaceutical Companies, Inc.” and “Par” are registered trademarks of Par Pharmaceutical Companies, Inc. The display of the aforementioned logos, trademarks and trade names does not constitute an endorsement by or on behalf of Par Pharmaceutical Companies, Inc.
Mylan has a commercialization and licensing agreement to market our pharmaceutical product AMITIZA in Japan.
The Mylan logo and Seeing Is Believing are marks of Mylan NV and its affiliates.
Gloria has a license, development, commercialization and supply agreement for our pharmaceutical product AMITIZA to develop and commercialize AMITIZA in the People’s Republic of China.
For Business Development inquiries please contact: